Blood Pressure Medication Recall: 3,744 Bottles of Olmesartan, Amlodipine and Hydrochlorothiazide Tablets Affected

A blood pressure medication recall is the removal of specific batches of a hypertension drug from the market because the product failed a quality or safety standard. Macleods Pharma USA has recalled 3,744 bottles of its olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in the United States. If you take this three-drug combination, check your bottle before you do anything else. Only two lots are affected. Do not stop taking your medication until you have spoken with a pharmacist or your prescriber. Blood Pressure Medication Recall at a Glance Detail Information Manufacturer Macleods Pharma USA Medication Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets Condition treated Hypertension (high blood pressure) Bottles recalled 3,744 Reason Failed dissolution specifications Recall started October 7, 2026 (voluntary) FDA classification Class II, assigned October 26, 2026 Expiration date May 31, 2027 Which Blood Pressure Medication Has Been Recalled? The recall covers two lots of generic olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets made by Macleods Pharma USA. Bottle size Bottles recalled Lot number NDC 30 tablets 3,528 12251163A 33342-246-07 90 tablets 216 12251163B 33342-246-10 The National Drug Code (NDC) is a unique number that identifies a drug product, its manufacturer and its package size. Both lots expire on May 31, 2027. The same three-drug combination is sold under the brand name Tribenzor. The recall does not include brand-name Tribenzor. It applies only to the Macleods generic lots listed above. Many other generic versions of this combination exist. The ingredient names alone do not tell you whether your tablets are affected. The manufacturer, lot number and NDC do. Why Did Macleods Pharma USA Recall These Tablets? Dissolution testing measures how quickly and how completely a tablet releases its active ingredients into liquid under controlled laboratory conditions. The release rate affects how much of each drug the body can absorb. This recall has a detail that single-ingredient recall do not. One tablet must release three different drugs at the expected pace. A failed test means the tablets did not meet the release standard the manufacturer set for them. Slower or lower release could reduce the amount of medicine that reaches the bloodstream, which would weaken blood pressure control. The test result does not show that every tablet in the two lots will fail to work. It also does not show that anyone who took these tablets has been harmed. It shows a manufacturing quality problem, and the recall exists to deal with that problem early. Does a Dissolution Failure Mean the Tablets Contain the Wrong Ingredients? No. A dissolution failure concerns how the ingredients are released, not which ingredients are in the tablet. The tablet may contain the correct drugs in the correct amounts and still release them too slowly. That difference matters because the risk is reduced effectiveness, not a harmful substance. It is also the reason a Class II classification fits this case. What Does an FDA Class II Recall Mean? A Class II recall applies when using or being exposed to a product may cause temporary or medically reversible health problems, or when the chance of serious harm is remote. The FDA sorts recalls into three classes based on risk. Class Meaning Class I Reasonable chance of serious health problems or death Class II Temporary or medically reversible health problems possible; serious harm unlikely Class III Use is unlikely to cause health problems Class II is the middle category. It does not declare the product safe, and it does not mean everyone who took the tablets will have a problem. For a blood pressure drug, the practical concern is that blood pressure may rise if the medicine works less well than intended. What Should Patients Do If They Have the Recalled Medication? Follow these steps in order: 1. Read your bottle. Look for the manufacturer name, the lot number (12251163A or 12251163B), the bottle size and the NDC. 2. Ask the pharmacy to check if the label does not show a lot number. Pharmacy-filled vials often carry only the pharmacy label. The pharmacy can look up the NDC and lot in its dispensing records. 3. Call your pharmacist or prescriber if your bottle matches. Ask for a replacement from an unaffected lot or manufacturer. 4. Keep taking your medicine until you have a replacement. Stopping a hypertension drug without guidance can allow blood pressure to climb and raise the risk of heart attack and stroke. 5. Do not change your dose by yourself. Doubling tablets or skipping doses creates its own risks. Watch Your Blood Pressure Readings If you own a home blood pressure monitor, record your readings for the next few weeks and share the log with your prescriber. A steady rise in readings gives your care team useful information. A reading of 180/120 mm Hg or higher, especially with chest pain, shortness of breath, vision changes, confusion or weakness, needs emergency care. What Do the Three Medicines in This Tablet Do? This combination treats high blood pressure through three separate mechanisms. Medicine Drug class Main action Olmesartan medoxomil Angiotensin II receptor blocker Relaxes blood vessels Amlodipine Calcium channel blocker Relaxes blood vessel walls and improves blood flow Hydrochlorothiazide Diuretic Helps the body remove excess salt and water through urine Prescribers choose a combination tablet when one medicine alone does not bring blood pressure to the target range. Hypertension often causes no symptoms, so a patient may not feel the difference if the medicine works less well. Home readings and regular checkups are the only reliable way to catch it. Author’s Note: In my view, the main lesson here is that a medicine’s generic name does not identify the exact product in your hand. Two bottles with identical ingredients can come from different manufacturers and different lots, and only one of them may be recalled. Patients who keep the original packaging, or who ask their pharmacy to note the manufacturer on their records, can answer a recall notice in minutes instead of days. Dissolution testing is one of the checks that confirms a tablet performs as intended, and this recall shows the system catching a problem. The Class II label indicates that serious consequences are unlikely. Even so, the most sensible response is to verify your lot, contact your pharmacist and keep your blood pressure treatment going while the replacement is arranged. For official recall details, patients and clinicians can search the FDA’s enforcement reports for the Macleods Pharma USA entry.

A blood pressure medication recall is the removal of specific batches of a hypertension drug from the market because the product failed a quality or safety standard. Macleods Pharma USA has recalled 3,744 bottles of its olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in the United States.

If you take this three-drug combination, check your bottle before you do anything else. Only two lots are affected. Do not stop taking your medication until you have spoken with a pharmacist or your prescriber.

Blood Pressure Medication Recall at a Glance

Detail Information
Manufacturer Macleods Pharma USA
Medication Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets
Condition treated Hypertension (high blood pressure)
Bottles recalled 3,744
Reason Failed dissolution specifications
Recall started October 7, 2026 (voluntary)
FDA classification Class II, assigned October 26, 2026
Expiration date May 31, 2027

Which Blood Pressure Medication Has Been Recalled?

The recall covers two lots of generic olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets made by Macleods Pharma USA.

Bottle size Bottles recalled Lot number NDC
30 tablets 3,528 12251163A 33342-246-07
90 tablets 216 12251163B 33342-246-10

The National Drug Code (NDC) is a unique number that identifies a drug product, its manufacturer and its package size. Both lots expire on May 31, 2027.

The same three-drug combination is sold under the brand name Tribenzor. The recall does not include brand-name Tribenzor. It applies only to the Macleods generic lots listed above.

Many other generic versions of this combination exist. The ingredient names alone do not tell you whether your tablets are affected. The manufacturer, lot number and NDC do.

Why Did Macleods Pharma USA Recall These Tablets?

Dissolution testing measures how quickly and how completely a tablet releases its active ingredients into liquid under controlled laboratory conditions. The release rate affects how much of each drug the body can absorb.

This recall has a detail that single-ingredient recall do not. One tablet must release three different drugs at the expected pace. A failed test means the tablets did not meet the release standard the manufacturer set for them. Slower or lower release could reduce the amount of medicine that reaches the bloodstream, which would weaken blood pressure control.

The test result does not show that every tablet in the two lots will fail to work. It also does not show that anyone who took these tablets has been harmed. It shows a manufacturing quality problem, and the recall exists to deal with that problem early.

Does a Dissolution Failure Mean the Tablets Contain the Wrong Ingredients?

No. A dissolution failure concerns how the ingredients are released, not which ingredients are in the tablet.

The tablet may contain the correct drugs in the correct amounts and still release them too slowly. That difference matters because the risk is reduced effectiveness, not a harmful substance. It is also the reason a Class II classification fits this case.

What Does an FDA Class II Recall Mean?

A Class II recall applies when using or being exposed to a product may cause temporary or medically reversible health problems, or when the chance of serious harm is remote. The FDA sorts recalls into three classes based on risk.

Class Meaning
Class I Reasonable chance of serious health problems or death
Class II Temporary or medically reversible health problems possible; serious harm unlikely
Class III Use is unlikely to cause health problems

Class II is the middle category. It does not declare the product safe, and it does not mean everyone who took the tablets will have a problem. For a blood pressure drug, the practical concern is that blood pressure may rise if the medicine works less well than intended.

What Should Patients Do If They Have the Recalled Medication?

Follow these steps in order:

  1. Read your bottle. Look for the manufacturer name, the lot number (12251163A or 12251163B), the bottle size and the NDC.
  2. Ask the pharmacy to check if the label does not show a lot number. Pharmacy-filled vials often carry only the pharmacy label. The pharmacy can look up the NDC and lot in its dispensing records.
  3. Call your pharmacist or prescriber if your bottle matches. Ask for a replacement from an unaffected lot or manufacturer.
  4. Keep taking your medicine until you have a replacement. Stopping a hypertension drug without guidance can allow blood pressure to climb and raise the risk of heart attack and stroke.
  5. Do not change your dose by yourself. Doubling tablets or skipping doses creates its own risks.

Watch Your Blood Pressure Readings

If you own a home blood pressure monitor, record your readings for the next few weeks and share the log with your prescriber. A steady rise in readings gives your care team useful information. A reading of 180/120 mm Hg or higher, especially with chest pain, shortness of breath, vision changes, confusion or weakness, needs emergency care.

What Do the Three Medicines in This Tablet Do?

This combination treats high blood pressure through three separate mechanisms.

Medicine Drug class Main action
Olmesartan medoxomil Angiotensin II receptor blocker Relaxes blood vessels
Amlodipine Calcium channel blocker Relaxes blood vessel walls and improves blood flow
Hydrochlorothiazide Diuretic Helps the body remove excess salt and water through urine

Prescribers choose a combination tablet when one medicine alone does not bring blood pressure to the target range. Hypertension often causes no symptoms, so a patient may not feel the difference if the medicine works less well. Home readings and regular checkups are the only reliable way to catch it.

Author’s Note:

In my view, the main lesson here is that a medicine’s generic name does not identify the exact product in your hand. Two bottles with identical ingredients can come from different manufacturers and different lots, and only one of them may be recalled. Patients who keep the original packaging, or who ask their pharmacy to note the manufacturer on their records, can answer a recall notice in minutes instead of days.

Dissolution testing is one of the checks that confirms a tablet performs as intended, and this recall shows the system catching a problem. The Class II label indicates that serious consequences are unlikely. Even so, the most sensible response is to verify your lot, contact your pharmacist and keep your blood pressure treatment going while the replacement is arranged.

For official recall details, patients and clinicians can search the FDA’s enforcement reports for the Macleods Pharma USA entry.

Share On:
Facebook
X
LinkedIn
Related Posts